Home > Search Results
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Treats advanced breast cancer in patients who have already received other types of breast cancer medicine. It is used alone or with another cancer medicine called capecitabine.

UsesSide effectsLatest evidence reviewsResearch summaries for consumersBrand names

Results: 4

Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer

The authors concluded that compared with capecitabine alone, ixabepilone plus capecitabine demonstrated a clinical activity with an acceptable safety profile in patients with locally-advanced breast cancer. There were concerns with trial quality and comparability, so caution is warranted when interpreting the authors? conclusions.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

BACKGROUND: Estramustine phosphate is a mustard-oestradiol conjugate, and has hormonal and non-hormonal effects. In phase II trials of patients with cancer, response to microtubule inhibitors increases when these drugs are combined with estramustine. We aimed to assess whether combining estramustine with chemotherapy increases survival in patients with castration-refractory prostate cancer.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2007

Pain (PDQ®): Health Professional Version

Expert-reviewed information summary about pain as a complication of cancer or its treatment. Approaches to the management and treatment of cancer-associated pain are discussed.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: September 3, 2014

Breast Cancer Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of ductal carcinoma in situ, lobular carcinoma in situ, and invasive breast cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: December 3, 2014

Systematic Reviews in PubMed

See all (12)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...